APOE ε4 influences the widespread TDP-43 pathological subtype in sporadic amyotrophic lateral sclerosis

Acta Neuropathologica · Published 2026-05-15 · DOI 10.1007/s00401-026-03029-y

Free full text

Authors (6)

Yuya Hatano, Asa Nakahara, Mari Tada, Akiyoshi Kakita, Osamu Onodera, Tomohiko Ishihara

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Hatano, Y., Nakahara, A., Tada, M., et al. (2026). APOE ε4 influences the widespread TDP-43 pathological subtype in sporadic amyotrophic lateral sclerosis. Acta Neuropathologica. https://doi.org/10.1007/s00401-026-03029-y

Related articles

• A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer’s disease · Acta Neuropathologica · 2026 · Same journal
• Retinal proteome changes mirror brain pathology and reveal synaptic and cytoskeletal dysfunction in Alzheimer’s disease · Acta Neuropathologica · 2026 · Same journal
• Molecular signatures and biomarker development for limbic-predominant age-related TDP-43 encephalopathy (LATE) · Acta Neuropathologica · 2026 · Same journal
• Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degeneration · Acta Neuropathologica · 2026 · Same journal
• Consensus statement on microglial and macrophage functions in gliomas · Acta Neuropathologica · 2026 · Same journal
• Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model · Acta Neuropathologica · 2026 · Same journal
• Altered astrocyte–neuron crosstalk in progressive supranuclear palsy: integrated evidence from proteomics and magnetic resonance spectroscopy · Acta Neuropathologica · 2026 · Same journal
• CTE-type tau filaments in Alzheimer’s disease with co-morbid LATE-NC · Acta Neuropathologica · 2026 · Same journal
• A severe neurodevelopmental syndrome linked to a South Asian founder variant in the UFMylation adaptor CDK5RAP3 · Acta Neuropathologica · 2026 · Same journal
• A novel BEND2 monoclonal antibody enables highly specific immunohistochemical diagnosis of BEND2-fusion astroblastomas · Acta Neuropathologica · 2026 · Same journal